gms | German Medical Science

68. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie

Nordrhein-Westfälische Gesellschaft für Urologie e. V.

30.03. - 31.03.2023, Essen

Artikel

Artikel empfehlen

Robot-assisted retroperitoneal lymph node dissection: feasibility and outcome in postchemotherapy large >5 cm residual mass in testicular cancer

Meeting Abstract

Suche in Medline nach

  • Ihab Abutabanjeh - Klinikum Herford, Herford, Germany
  • Husam Abuhilal - Klinikum Herford, Herford, Germany
  • Tim Schäfer - Klinikum Herford, Herford, Germany
  • Raisa Abrams-Pompe - Klinikum Herford, Herford, Germany
  • presenting/speaker Christian Meyer - Klinikum Herford, Herford, Germany

Nordrhein-Westfälische Gesellschaft für Urologie. 68. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie. Essen, 30.-31.03.2023. Düsseldorf: German Medical Science GMS Publishing House; 2023. DocP 1.5

doi: 10.3205/23nrwgu40, urn:nbn:de:0183-23nrwgu400

Veröffentlicht: 28. März 2023

© 2023 Abutabanjeh et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.

Gliederung

Text

Introduction: Retroperitoneal resection is an acknowledged part in the treatment of testicular cancer. The robotic approach has traditionally been reserved for small tumors. We aimed to evaluate the surgical feasibility, complication, and oncological outcome of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in patients with large > 5 cm residual retroperitoneal masses.

Methods: A total of 3 patients underwent RA-RPLND between January 2022 and September 2022 at our Department. Data were collected retrospectively and prospectively regarding patient demography, tumor characteristics, surgical, pathological and oncological outcome.

Results: RA-RPLND was successfully completed in all the 3 patients. Supine robotic approach was used in unilateral dissection in 3 patients. Median operative time was 150 min, median estimated blood loss was 120 ml, and median length of hospital stay was 4 days. The median yield of lymph node was10. No patients developed achyle leak.

Conclusion: RA-RPLND seems to be a safe and feasible approach for large (> 5 cm) residual masses after chemotherapy with accepted complication rates. Larger studies are required to establish its diagnostic and therapeutic utility.